Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Differentiation; Research in Biological Diversity|March 11, 2009
Derivation, characterization and gene modification of cynomolgus monkey mesenchymal stem cellsHui Ke, Peng Wang, Weihua Yu, et al.
Frontiers in Pharmacology|September 2, 2025
Pharmacological properties and therapeutic potential of berberine: a comprehensive reviewKe-Qin Fan, Liangming Zhang, Fangyu Song, et al.
BMC Musculoskeletal Disorders|August 18, 2020
Percutaneous transforaminal full endoscopic decompression for the treatment of lumbar spinal stenosisPeigen Xie, Feng Feng, Zihao Chen, et al.
BMJ Open|September 25, 2024
Unilateral biportal endoscopic versus microscopic transforaminal lumbar interbody fusion for degenerative lumbar spinal stenosis in China: study protocol for a prospective, randomised, controlled, non-inferiority trialZizhao Wu, Ting Luo, Yang Yang, et al.
BMC Medicine|July 7, 2024
Global incidence and characteristics of spinal cord injury since 2000-2021: a systematic review and meta-analysisYubao Lu, Zhizhong Shang, Wei Zhang, et al.
Spine|September 9, 2022
Percutaneous Transforaminal Endoscopic Discectomy Versus Microendoscopic Discectomy for Lumbar Disk Herniation: Five-year Results of a Randomized Controlled TrialZihao Chen, Liangming Zhang, Jianwen Dong, et al.
Neural Regeneration Research|December 30, 2025
Spatiotemporal disarray of inflammatory microenvironment following spinal cord injuryJiawei Di, Yubao Lu, Senyu Yao, et al.
Journal of Neurosurgery. Spine|January 6, 2018
Percutaneous transforaminal endoscopic discectomy compared with microendoscopic discectomy for lumbar disc herniation: 1-year results of an ongoing randomized controlled trialZihao Chen, Liangming Zhang, Jianwen Dong, et al.
Scientific Reports|November 7, 2025
Exploring the molecular mechanism of apigenin in treating bronchiectasis based on network pharmacology and molecular dockingHaizhu Huang, Jiahui Han, Yanping Liu, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 7, 2021
Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence TrialBinghe Xu, Qingyuan Zhang, Tao Sun, et al.
Pageof 12